Clinical Trials
2 trialsNCT06327698 2024-03-25
Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
Hunan Cancer Hospital
Phase 2 Not yet recruiting
NCT04979585 2021-08-03
Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma
The First Hospital of Jilin University
Phase 2 Unknown